Immuneering Corp - Ordinary Shares Class A
IMRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$185.5M
Close$
$2.84
45.6% downside
Current Fair Value
45.6% downsideOvervalued by 45.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $185.50 Million |
|---|---|
| Enterprise Value | $-43,405,857,053.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 0.41 |
| Outstanding Shares | 44,011,830 |
Return
| Return on Equity | -13.78% |
|---|---|
| Return on Assets | -13.25% |
| Return on Invested Capital | -14.45% |
Valuation & Multiples
| P/E Ratio | -4.37 |
|---|---|
| PEG | 41.45 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.43 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 165.61% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.53%▼ 66.05% |
|---|---|
| Total Invested | $1.17M▼ 99.24% |
| Investors Holding | 4▼ 97.00% |
ESG Score
No data
About Immuneering Corp
2,021 employees